Patent · US Active

Compositions and methods for the prevention and treatment of hearing loss

US11433073B2 · kind B2 · utility

1Cited by
23References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2022
Grant dateSep 6, 2022
Priority date—
Expiry dateJan 21, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Method, kit and pharmaceutical compositions using an inhibitor of EGFR signaling for prevention or treatment of hearing loss are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.